Seeing Is Believing
Healthcare - Sector
HALO is currently covered by 11 analysts with an average price target of $76.96. This is a potential upside of $7.24 (-5.65%) from yesterday's end of day stock price of $81.57.
Halozyme Therapeutics's activity chart (see below) currently has 179 price targets and 151 ratings on display. The stock rating distribution of HALO is 37.04% HOLD, 59.26% BUY and 3.7% SELL.
Analysts average stock forecasts to be materialized ratio is 82.01% with an average time for these price targets to be met of 243.06 days.
Highest price target for HALO is $93, Lowest price target is $56, average price target is $76.96.
Most recent stock forecast was given by from MORGAN STANLEY on 12-May-2026. First documented stock forecast 12-Jun-2014.
Currently out of the existing stock ratings of HALO, 10 are a HOLD (37.04%), 16 are a BUY (59.26%), 1 are a SELL (3.7%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Aug-2025
$93
$18.04 (24.07%)
$79
1 months 26 days ago
(12-May-2026)
11/12 (91.67%)
$22.07 (31.12%)
270
Hold Since 13-Jan-2025
$75
$0.04 (0.05%)
$65
4 months 19 days ago
(19-Feb-2026)
9/10 (90%)
$2.96 (4.11%)
291
Buy Since 24-Sep-2025
$90
$15.04 (20.06%)
$90
4 months 19 days ago
(19-Feb-2026)
10/12 (83.33%)
$17.96 (24.93%)
286
Buy Since 29-Feb-2024
$90
$15.04 (20.06%)
$79
6 months ago
(08-Jan-2026)
7/8 (87.5%)
$17.87 (24.77%)
209
Buy Since 24-Jul-2023
$90
$15.04 (20.06%)
$90
6 months 19 days ago
(19-Dec-2025)
32/38 (84.21%)
$22.65 (33.63%)
177
What is HALO (Halozyme Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on HALO (Halozyme Therapeutics) with a proven track record?
Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?
Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?
Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?